BenevolentAI Investor Conference Presentation Deck
Fundamental shift in Al
landscape, with BAI
strongly positioned
We are applying our core Al and data
foundations to create new commercial
opportunities
Our new generative Al products
leverage our expertise in natural
language processing and experience in
drug discovery
Built on 5+ years of development in
pharma technologies that solve
challenging problems in discovery and
research
New Knowledge Exploration tools
Our new customisable SaaS products enable scientists to make higher-confidence
decisions and improve discovery and research productivity
BenAl-Q
●
Investigate, visualise and analyse multi-modal data in real-time
• Standardise workflows and automate daily research tasks
• Curated platform leveraging our Knowledge Graph, bespoke
Large Language Models (LLMs) and other core technologies
BenAl Research Assistant
Speed up reading and reviewing scientific literature
Facilitates greater contextual understanding through a web
browser extension
●
Knowledge Exploration
●
Go-to-market plan
Evolving products to match customer and scientist needs,
based on user testing and market research
• Focus on large and mid-sized biopharma customers
• Commercial function build-out in progress
Targeting potential go-to-market partners
●
BenevolentAl Proprietary
Benevolent
8View entire presentation